Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn’s disease with Guselkumab

Dr. Vincent Piguet has received honoraria or fees for consulting and/or speaking for AbbVie, Almirall, Celgene, Janssen, Novartis and Pfizer, and has received departmental support for Cardiff University from AbbVie, Almirall, Alliance, Beiersdorf UK Ltd., Biotest, Celgene, Dermal, Eli Lilly, Galderma, Genus Pharma, Globe Micro, Janssen-Celag, La Roche-Posay, L'Oreal, LEO Pharma, Meda, MSD, Novartis, Pfizer, Sinclair Pharma, Spirit, Stiefel, Samumed, Thornton Ross, TyPham and UCB, and for University of Toronto from Sanofi. Requests for additional data may be made directly to the corresponding authors.